Mitigating Paxlovid™-induced drug-drug interaction toxicity: an in silico insight

被引：0
|
作者：
Ta, Giang H. [1 ]
Leong, Max K. [1 ]
机构：
[1] Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
关键词：
<italic>in silico</italic>; skin permeability; Paxlovid; nirmatrelvir; COVID-19; PENETRATION; PERMEATION; SKIN;
D O I：
10.3389/fphar.2024.1496630
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The clinical drug-drug interaction side-effects of Ritonavir, an ingredient in Paxlovid (TM), have been documented, highlighting the need to explore alternative administration methods for Nirmatrelvir, another drug in the Paxlovid (TM) combination. In this study, the skin permeability potential of Nirmatrelvir was assessed using various in silico models. The prediction results suggest that Nirmatrelvir could be administrated via the transdermal route, offering a promising avenue to enhance the efficacy of anti-COVID-19 agents.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comparison of clinical drug-drug interaction study results for sunitinib and axitinib with an in silico tool
    Rahavendran, Sadayappan V.
    Pithavala, Yazdi K.
    Bello, Carlo
    Klamerus, Karen J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 82 - 82
  • [22] Meropenem/valproic-acidOverdose, drug toxicity and drug-drug pharmacokinetic interaction : case report
    Reactions Weekly, 2024, 2021 (1) : 293 - 293
  • [23] Cyclosporine exacerbates ketamine toxicity in zebrafish: Mechanistic studies on drug-drug interaction
    Robinson, Bonnie L.
    Dumas, Melanie
    Ali, Syed F.
    Paule, Merle G.
    Gu, Qiang
    Kanungo, Jyotshna
    JOURNAL OF APPLIED TOXICOLOGY, 2017, 37 (12) : 1438 - 1447
  • [24] Drug Repurposing Based on Drug-Drug Interaction
    Zhou, Bin
    Wang, Rong
    Wu, Ping
    Kong, De-Xin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (02) : 137 - 144
  • [25] Application of in silico approaches to predicting drug-drug interactions
    Ekins, S
    Wrighton, SA
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2001, 45 (01) : 65 - 69
  • [26] MecDDI: Clarified Drug-Drug Interaction Mechanism Facilitating Rational Drug Use and Potential Drug-Drug Interaction Prediction
    Hu, Wei
    Zhang, Wei
    Zhou, Ying
    Luo, Yongchao
    Sun, Xiuna
    Xu, Huimin
    Shi, Shuiyang
    Li, Teng
    Xu, Yichao
    Yang, Qianqian
    Qiu, Yunqing
    Zhu, Feng
    Dai, Haibin
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (05) : 1626 - 1636
  • [27] Assessment of drug-drug interaction for silymarin
    Doehmer, Johannes
    Tewes, Bernhard
    Klein, Kai-Uwe
    Gritzko, Kristin
    Muschick, Holger
    Mengs, Ulrich
    TOXICOLOGY IN VITRO, 2008, 22 (03) : 610 - 617
  • [28] The economic consequences of a drug-drug interaction
    Shad, MU
    Marsh, C
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) : 119 - 120
  • [29] DRUG-DRUG INTERACTION PREDICTION ASSESSMENT
    Zhou, Jihao
    Qin, Zhaohui
    Sara, Quinney K.
    Kim, Seongho
    Wang, Zhiping
    Hall, Stephen D.
    Li, Lang
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (04) : 641 - 657
  • [30] Paxlovid Drug Interaction Screening Checklist Updated
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (13): : 1290 - 1290
12345